Literature DB >> 22824477

The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.

Mangesh R Pagadala1, Arthur J McCullough.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most prevalent chronic liver disease. Nonalcoholic steatohepatitis (NASH), the more severe form of NAFLD, has an increased risk for progression to cirrhosis. The available data suggest increased morbidity and mortality among those patients with advanced histologic severity such as NASH and fibrosis. Despite the lack of a universally accepted histologic definition of NAFLD and inconsistency among pathologists regarding histologic findings essential to the diagnosis of NASH, a few studies have identified specific histologic findings (particularly fibrosis regardless of stage) that are able to predict NAFLD-related mortality as being most important.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22824477      PMCID: PMC4176889          DOI: 10.1016/j.cld.2012.05.006

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  78 in total

Review 1.  Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.

Authors:  Leon A Adams; Ariel E Feldstein
Journal:  J Dig Dis       Date:  2011-02       Impact factor: 2.325

2.  Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.

Authors:  Maria Stepanova; Zobair M Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-13       Impact factor: 11.382

3.  Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.

Authors:  Leon A Adams; Scott Harmsen; Jennifer L St Sauver; Phunchai Charatcharoenwitthaya; Felicity B Enders; Terry Therneau; Paul Angulo
Journal:  Am J Gastroenterol       Date:  2010-02-09       Impact factor: 10.864

4.  Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?

Authors:  Jeremy P Domanski; Stephen J Park; Stephen A Harrison
Journal:  J Clin Gastroenterol       Date:  2012 May-Jun       Impact factor: 3.062

5.  Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.

Authors:  Raphael B Merriman; Linda D Ferrell; Marco G Patti; Shiobhan R Weston; Mark S Pabst; Bradley E Aouizerat; Nathan M Bass
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.

Authors:  Shahid M Malik; Michael E Devera; Paulo Fontes; Obaid Shaikh; Eizaburo Sasatomi; Jawad Ahmad
Journal:  Liver Transpl       Date:  2009-12       Impact factor: 5.799

8.  Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

Authors:  Jason M Hui; James G Kench; Shivakumar Chitturi; Archana Sud; Geoffrey C Farrell; Karen Byth; Pauline Hall; Mahbub Khan; Jacob George
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

9.  Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.

Authors:  Ariel E Feldstein; Anna Wieckowska; A Rocio Lopez; Yao-Chang Liu; Nizar N Zein; Arthur J McCullough
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

10.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  17 in total

Review 1.  Micro RNAs in the development of non-alcoholic fatty liver disease.

Authors:  Glenn S Gerhard; Johanna K DiStefano
Journal:  World J Hepatol       Date:  2015-02-27

2.  Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.

Authors:  Saumya Jayakumar; Stephen A Harrison; Rohit Loomba
Journal:  Curr Hepatol Rep       Date:  2016-04-21

3.  Total body weight loss of ≥ 10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  Lisa M Glass; Rolland C Dickson; Joseph C Anderson; Arief A Suriawinata; Juan Putra; Brian S Berk; Arifa Toor
Journal:  Dig Dis Sci       Date:  2014-10-30       Impact factor: 3.199

4.  Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis.

Authors:  Srinivasan Dasarathy; Jaividhya Dasarathy; Amer Khiyami; Lisa Yerian; Carol Hawkins; Ruth Sargent; Arthur J McCullough
Journal:  J Clin Gastroenterol       Date:  2015-02       Impact factor: 3.062

Review 5.  Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy.

Authors:  Cristiane Valle Tovo; Angelo Zambam de Mattos; Gabriela Perdomo Coral; Fernanda Schild Branco; Eiji Suwa; Angelo Alves de Mattos
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

Review 6.  Choline's role in maintaining liver function: new evidence for epigenetic mechanisms.

Authors:  Mihai G Mehedint; Steven H Zeisel
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-05       Impact factor: 4.294

7.  Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease.

Authors:  Cynthia A Moylan; Herbert Pang; Andrew Dellinger; Ayako Suzuki; Melanie E Garrett; Cynthia D Guy; Susan K Murphy; Allison E Ashley-Koch; Steve S Choi; Gregory A Michelotti; Daniel D Hampton; Yuping Chen; Hans L Tillmann; Michael A Hauser; Manal F Abdelmalek; Anna Mae Diehl
Journal:  Hepatology       Date:  2013-12-13       Impact factor: 17.425

8.  Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis.

Authors:  Goh Eun Chung; Donghee Kim
Journal:  Clin Mol Hepatol       Date:  2013-06-27

9.  Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients.

Authors:  George Boon-Bee Goh; Mangesh R Pagadala; Jaividhya Dasarathy; Aynur Unalp-Arida; Ruth Sargent; Carol Hawkins; Achuthan Sourianarayanane; Amer Khiyami; Lisa Yerian; Rish K Pai; Srinivasan Dasarathy; Arthur J McCullough
Journal:  BBA Clin       Date:  2014-09-20

10.  Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis.

Authors:  Wenxia Lu; Sainan Li; Jingjing Li; Jianrong Wang; Rong Zhang; Yuqing Zhou; Qin Yin; Yuanyuan Zheng; Fan Wang; Yujing Xia; Kan Chen; Tong Liu; Jie Lu; Yingqun Zhou; Chuanyong Guo
Journal:  Gastroenterol Res Pract       Date:  2016-08-29       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.